New advances in DPYD genotype and risk of severe toxicity under capecitabine

BACKGROUND: Deficiency in dihydropyrimidine dehydrogenase (DPD) enzyme is the main cause of severe and lethal fluoropyrimidine-related toxicity. Various approaches have been developed for DPD-deficiency screening, including DPYD genotyping and phenotyping. The goal of this prospective observational...

Descripción completa

Detalles Bibliográficos
Autores principales: Etienne-Grimaldi, Marie-Christine, Boyer, Jean-Christophe, Beroud, Christophe, Mbatchi, Litaty, van Kuilenburg, André, Bobin-Dubigeon, Christine, Thomas, Fabienne, Chatelut, Etienne, Merlin, Jean-Louis, Pinguet, Frédéric, Ferrand, Christophe, Meijer, Judith, Evrard, Alexandre, Llorca, Laurence, Romieu, Gilles, Follana, Philippe, Bachelot, Thomas, Chaigneau, Loic, Pivot, Xavier, Dieras, Véronique, Largillier, Rémy, Mousseau, Mireille, Goncalves, Anthony, Roché, Henri, Bonneterre, Jacques, Servent, Véronique, Dohollou, Nadine, Château, Yann, Chamorey, Emmanuel, Desvignes, Jean-Pierre, Salgado, David, Ferrero, Jean-Marc, Milano, Gérard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421769/
https://www.ncbi.nlm.nih.gov/pubmed/28481884
http://dx.doi.org/10.1371/journal.pone.0175998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421769/
https://www.ncbi.nlm.nih.gov/pubmed/28481884
http://dx.doi.org/10.1371/journal.pone.0175998

Ejemplares similares